Open AccessOral rather than intravenous corticosteroids should be used to treat MS relapses – Yes
Author(s) -
Emmanuelle Le Page,
Gilles Edan
Publication year - 2017
Publication title -
multiple sclerosis journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.729
H-Index - 131
eISSN - 1477-0970
pISSN - 1352-4585
DOI - 10.1177/1352458517695893
Subject(s) - multiple sclerosis , medicine , disease , adrenal cortex hormones , surgery , intensive care medicine , immunology
International audienceThe therapeutic arsenal for preventing multiple sclerosis (MS) relapses strongly improved over the last 20 years with more than 10 disease-modifying drugs now available. However, relapses can still occur, requiring treatment with corticosteroids to accelerate recovery..
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom